This file is part of IDEAS, which uses RePEc data


[ Papers | Articles | Software | Books | Chapters | Authors | Institutions | JEL Classification | NEP reports | Search | New papers by email | Author registration | Rankings | Volunteers | FAQ | Blog | Help! ]

Le rôle des capital-risqueurs dans l'isomorphisme stratégique des "biotechs"

Author info | Abstract | Publisher info | Download info | Related research | Statistics
Author Info
Emmanuelle Dubocage () (Université de Paris-Sud)
Géraldine Galindo () (Université de Paris-Sud)
Abstract

(VF)Grâce à une démarche exploratoire hybride, nous montrons comment, par leur intervention active dans la gestion, les capital-risqueurs gèrent les incertitudes radicales sur le devenir des jeunes entreprises innovantes de haute technologie (JEIHT) de biotechnologie. Cette intervention dans la gestion débouche sur l'isomorphisme stratégique de ces entreprises vers un modèle combinant recherche de produits et/ou de techniques, d'une part, et vente de services, d'autre part. L'origine de cet isomorphisme réside dans le mimétisme des entreprises mais également dans celui des capital-risqueurs. Enfin, nous discutons des conséquences de ce phénomène en termes de performance pour les entreprises.(VA)In this exploratory study, we show how ventrue capitaliste manage the radical uncertainties concerning the future of young innovative high-tech biotechnology tirms (JEIHT) through their active involvement in management. VCs' impact on management leads to strategic isomorphism of biotech firme towards a model combining research on products and/or technologies on the one hand and service offers, on the other. The origine of this isomorphism lie in the mimetic behavior of the biotech Cirms, as well as in the mimetism of venture capitaliste. Finally, we discuss the consequences of this phenomenon in terme of counpany performance.

Download Info
To our knowledge, this item is not available for download. To find whether it is available, there are three options:
1. Check below under "Related research" whether another version of this item is available online.
2. Check on the provider's web page whether it is in fact available.
3. Perform a search for a similarly titled item that would be available.

Publisher Info
Article provided by Editions Economica in its journal Revue Finance Contrôle Stratégie.

Volume (Year): 11 (2008)
Issue (Month): 4 (December)
Pages: 5-30
Download reference. The following formats are available: HTML (with abstract), plain text (with abstract), BibTeX, RIS (EndNote, RefMan, ProCite), ReDIF
Handle: RePEc:dij:revfcs:v:11:y:2008:i:q4:p:5-30

Contact details of provider:
Postal: 49,rue Héricart,75015 Paris, France
Phone: +33(0)145781292
Fax: +33(0)145750567
Web page: http://www.economica.fr/

Order Information:
Postal: Economica, 49,rue Héricart, 75015 Paris, France

For technical questions regarding this item, or to correct its listing, contact: (Gérard Charreaux).

Related research
Keywords: biotechnologie; capital-risque; isomorphisme stratégique; mimétisme; performance; biotechnology; venture-capital; strategic isomorphism; mimetism; performance.;

Find related papers by JEL classification:
G32 - Financial Economics - - Corporate Finance and Governance - - - Financing Policy; Capital and Ownership Structure
L21 - Industrial Organization - - Firm Objectives, Organization, and Behavior - - - Business Objectives of the Firm

Statistics
Access and download statistics

Did you know? Each page is provided with a technical contact, in case something is not right with the supplied information. See under "publisher info".

This page was last updated on 2009-11-4.


This information is provided to you by IDEAS at the Department of Economics, College of Liberal Arts and Sciences, University of Connecticut using RePEc data on a server sponsored by the Society for Economic Dynamics.